The Journal of Immunology, Vol 152, Issue 12 5957-5968, Copyright © 1994 by American Association of Immunologists

ARTICLES

B cell differentiation defects in common variable immunodeficiency are ameliorated after stimulation with anti-CD40 antibody and IL-10

EM Eisenstein, K Chua and W Strober
Mucosal Immunity Section, National Institute of Allergy and Infectious Disease, Bethesda, MD 20892.

In these studies we show that although purified B cells of patients with common variable immunodeficiency (CVI) have a normal capacity to proliferate, they manifest differentiation defects at multiple levels. Compared with controls, circulating CVI B cell populations contain reduced numbers of sIgG+ and sIgA+ cells with a commensurate increase in sIgM+ B cells, suggesting an in vivo defect in isotype switch. In addition, CVI B cells manifest Ig secretion defects on stimulation with either anti-CD40 and IL-10 or SAC and IL-2 and IL-10, which are of increasing severity for IgM, IgG, and IgA, respectively. These Ig secretion defects are not overcome by addition of a variety of cytokines, including TGF-beta, to anti-CD40-driven cultures. In further studies we show that despite the above abnormalities, CVI B cells are induced to express normal or near-normal levels of C mu, C gamma, and C alpha mRNA after 7 days of stimulation with anti-CD40 and IL-10. That this CH mRNA expression represents a recovery of CVI B cell differentiation is supported by studies of Ig secretion in which CVI B cells that are first stimulated for 7 days with anti-CD40 and IL-10 and then restimulated in coculture with activated normal allogeneic T cells and IL-10, secrete substantial levels of IgM and IgG and increased amounts of IgA. Overall, therefore, CVI B cell function can be significantly improved by maintenance in culture. These data suggest the abnormalities of B cell differentiation in CVI are reversible and that the defect is a form of B cell anergy.

This article has been cited by other articles:

				C. Cunningham-Rundles, L. Radigan, A. K. Knight, L. Zhang, L. Bauer, and A. Nakazawa TLR9 Activation Is Defective in Common Variable Immune Deficiency J. Immunol., February 1, 2006; 176(3): 1978 - 1987. [Abstract] [Full Text] [PDF]

				A. M. Holm, P. Aukrust, E. M. Aandahl, F. Muller, K. Tasken, and S. S. Froland Impaired Secretion of IL-10 by T Cells from Patients with Common Variable Immunodeficiency-Involvement of Protein Kinase A Type I J. Immunol., June 1, 2003; 170(11): 5772 - 5777. [Abstract] [Full Text] [PDF]

				A. Kitani, K. Chua, K. Nakamura, and W. Strober Activated Self-MHC-Reactive T Cells Have the Cytokine Phenotype of Th3/T Regulatory Cell 1 T Cells J. Immunol., July 15, 2000; 165(2): 691 - 702. [Abstract] [Full Text] [PDF]

				A. Bhushan, B. Barnhart, S. Shone, C. Song, and L. R. Covey A Transcriptional Defect Underlies B Lymphocyte Dysfunction in a Patient Diagnosed with Non-X-Linked Hyper-IgM Syndrome J. Immunol., March 15, 2000; 164(6): 2871 - 2880. [Abstract] [Full Text] [PDF]

				R. Schwartz, Y. B.-A. Porat, Z. Handzel, Z. Sthoeger, B.-Z. Garty, R. Confino-Cohen, J. Levy, and I. Zan-Bar Identification of a Subset of Common Variable Immunodeficiency Patients with Impaired B-Cell Protein Tyrosine Phosphorylation Clin. Vaccine Immunol., November 1, 1999; 6(6): 856 - 860. [Abstract] [Full Text] [PDF]

				M. Wykes, A. Pombo, C. Jenkins, and G. G. MacPherson Dendritic Cells Interact Directly with Naive B Lymphocytes to Transfer Antigen and Initiate Class Switching in a Primary T-Dependent Response J. Immunol., August 1, 1998; 161(3): 1313 - 1319. [Abstract] [Full Text] [PDF]